Trinity Biotech (NASDAQ:TRIB) Earns Hold Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the stock. Trinity Biotech Price ...
Trinity Biotech plc: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
Trinity Biotech reports leap in CGM system accuracy
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), a leader in diabetes management solutions currently trading at $0.86 per share, has announced significant enhancements in the performance of its continuous ...
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq ...
Investing14d
Trinity Biotech secures US funding for HIV tests
DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, today announced the continuation of U.S. government funding for its HIV ...
PR Newswire18d
The Biotech Growth Trust PLC - Transaction in Own Shares
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate ...